New or worsening reflux symptoms that don't respond to simple measures should be discussed, as GLP-1 medications are not recommended in severe gastrointestinal disease
GLP-1 medications are best viewed as: A supportive treatment, especially for people with obesity A tool that may reduce severity and improve symptoms Part of a broader treatment plan that includes lifestyle changes Some people may still need CPAP even after losing weight
"There's some data to suggest that a dose tapering strategy, so where you minimize or lower the doses over time might prevent weight regain."
[1] [2] Available under brand names including Ozempic, Wegovy, and Rybelsus, this medication mimics the action of naturally occurring GLP-1, a hormone that plays multiple roles in glucose metabolism and appetite regulation
By mimicking naturally occurring peptides, this therapy can stimulate cellular repair, optimize metabolism, and enhance cognitive function
Yes, the FDA has approved semaglutide (Wegovy) and liraglutide (Saxenda) for adolescents aged 12 years and older who have a BMI at or above the 95th percentile for their age and sex